Furthermore, knocking down APRIL in initial cultures of colon cancer cells, as well as mouse and human CRC cell lines, reduced tumor clonogenicity and in vivo growth, which is in accordance with other publications. This evidence concerns the gene TNFSF13 and colorectal carcinoma.